TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive NCI To Establish New Offices for Special Populations, Survivorship, Klausner Tells House appropirations Subcommittee May 3, 1996
TCL Archive ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number June 17, 2011
TCL Archive Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL July 11, 2014